Indeed, many of the SAMD9/SAMD9L mutations originally described by our group in pediatric MDS were found in patients with refractory cytopenia of childhood [2], which is predominantly associated with a hypocellular BM phenotype. Here, SAMD9L is linked to myelodysplastic syndrome.